Kimberley Holt

2.0k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

Kimberley Holt is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Kimberley Holt has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 7 papers in Emergency Medical Services. Recurrent topics in Kimberley Holt's work include Respiratory and Cough-Related Research (35 papers), Asthma and respiratory diseases (20 papers) and Pediatric health and respiratory diseases (7 papers). Kimberley Holt is often cited by papers focused on Respiratory and Cough-Related Research (35 papers), Asthma and respiratory diseases (20 papers) and Pediatric health and respiratory diseases (7 papers). Kimberley Holt collaborates with scholars based in United Kingdom, United States and Canada. Kimberley Holt's co-authors include John A. Smith, Rachel Dockry, Anthony Ford, Rayid Abdulqawi, Bruce G. McCarthy, Gary Layton, Ashley Woodcock, Saifudin Khalid, Imran Satia and Angela Kelsall and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Kimberley Holt

37 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

2014 349 citations Rayid Abdulqawi, Rachel Dockry et al. The Lancet profile →

Peers

Countries citing papers authored by Kimberley Holt

Since Specialization

Citations

This map shows the geographic impact of Kimberley Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberley Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberley Holt more than expected).

Fields of papers citing papers by Kimberley Holt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberley Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberley Holt. The network helps show where Kimberley Holt may publish in the future.

Co-authorship network of co-authors of Kimberley Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberley Holt. A scholar is included among the top collaborators of Kimberley Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberley Holt. Kimberley Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mepolizumab for the Treatment of Refractory Chronic Cough With Eosinophilic Airways Disease (MUCOSA): A Randomized, Double-blind, Placebo-controlled Trial 2025 ·American Journal of Respiratory and Critical Care Medicine ·Nabil Diab, (unknown), Elena Kum, (unknown), Waleed Hassan, Suzanne Beaudin, (unknown), Jennifer Wattie, (unknown), Karen Howie, (unknown), Kimberley Holt, Roma Sehmi, (unknown), J. P. Smith, Paul M. O’Byrne, Imran Satia	1
2	Protocol for a double-blind crossover randomised controlled trial to investigate inhalation challenge to assess inducible laryngeal obstruction: CH-ILO 2024 ·ERJ Open Research ·Jemma Haines, Maria G. Belvisi, Eric Dubuis, Rachel Dockry, Kimberley Holt, James H. Hull, Janelle Yorke, Stephen J. Fowler, John A. Smith	0
3	An exploration of clinically meaningful definitions of cough bouts 2024 ·ERJ Open Research ·Kimberley Holt, Rachel Dockry, Kevin McGuinness, (unknown), John A. Smith	1
4	Development and validation of a novel questionnaire to describe and assess sensations and triggers associated with refractory and unexplained chronic cough 2024 ·BMJ Open Respiratory Research ·(unknown), (unknown), (unknown), Rachel Dockry, (unknown), Kimberley Holt, (unknown), (unknown), (unknown), Francesca Solari, John A. Smith, Janelle Yorke	3
5	Novel capsaicin cough endpoints effectively discriminate between healthy controls and patients with refractory chronic cough 2023 ·Respiratory Medicine ·Kimberley Holt, John Belcher, John A. Smith	5
6	Objective measurement of cough 2023 ·Kimberley Holt, Rachel Dockry, (unknown), John A. Smith	1
7	P214 Central Nervous System resting-state fMRI in refractory/unexplained chronic cough 2023 ·Research Explorer (The University of Manchester) ·(unknown), Rachel Dockry, (unknown), Shane McKie, Laura M. Parkes, Kyle T.S. Pattinson, (unknown), (unknown), Kimberley Holt, Philip J. Turner, (unknown), (unknown), Paul Marsden, JA Smith	0
8	An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough 2021 ·ERJ Open Research ·Rayid Abdulqawi, Imran Satia, Kimberley Holt, Rachel Dockry, (unknown), John A. Smith	4
9	A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Rayid Abdulqawi, Imran Satia, Yoshihiro Kanemitsu, Saifudin Khalid, Kimberley Holt, Rachel Dockry, Ashley Woodcock, John A. Smith	16
10	The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough 2020 ·European Respiratory Journal ·Emma Hilton, Imran Satia, Kimberley Holt, Ashley Woodcock, John Belcher, John A. Smith	28
11	Gefapixant in two randomised dose-escalation studies in chronic cough 2020 ·European Respiratory Journal ·John A. Smith, Michael M. Kitt, P. Butera, Steven A. Smith, Yuping Li, Zhi Jin Xu, Kimberley Holt, (unknown), Mandel Sher, Anthony Ford	97
12	Cough in Patients With Lung Cancer 2018 ·CHEST Journal ·Amélie Harle, Fiona Blackhall, Alex Molassiotis, Janelle Yorke, Rachel Dockry, Kimberley Holt, (unknown), Katie Baker, John A. Smith	31
13	XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough 2017 ·American Journal of Respiratory and Critical Care Medicine ·Maria G. Belvisi, Mark A. Birrell, Michael A. Wortley, Sarah A. Maher, Imran Satia, Huda Badri, Kimberley Holt, Patrick Round, Lorcan McGarvey, John Ford, John A. Smith	121
14	Neurophenotypes in Airway Diseases: Insights from Translational Cough Studies 2016 ·American Journal of Respiratory and Critical Care Medicine ·Maria G. Belvisi, Mark A. Birrell, Saifudin Khalid, Michael A. Wortley, Rachel Dockry, Julie Coote, Kimberley Holt, Eric Dubuis, Angela Kelsall, Sarah A. Maher, Sara J. Bonvini, Ashley Woodcock, John A. Smith	97
15	Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunction 2016 ·Journal of Allergy and Clinical Immunology ·Imran Satia, Nikolaos Tsamandouras, Kimberley Holt, Huda Badri, Mark Woodhead, Kayode Ogungbenro, Timothy Felton, Paul M. O’Byrne, Stephen J. Fowler, John A. Smith	65
16	TRPV1 Antagonism in Refractory Chronic Cough: A Double Blind Randomised Controlled Trial 2014 ·Journal of Allergy and Clinical Immunology ·Saifudin Khalid, Robert Murdoch, Amy Newlands, Kevin Smart, Angela Kelsall, Kimberley Holt, Rachel Dockry, Ashley Woodcock, John A. Smith	1
17	P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study breakdown → 2014 ·The Lancet ·Rayid Abdulqawi, Rachel Dockry, Kimberley Holt, Gary Layton, Bruce G. McCarthy, Anthony Ford, John A. Smith	349
18	Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial 2014 ·Journal of Allergy and Clinical Immunology ·Saifudin Khalid, Robert Murdoch, Amy Newlands, Kevin Smart, Angela Kelsall, Kimberley Holt, Rachel Dockry, Ashley Woodcock, John A. Smith	143
19	Data reduction for cough studies using distribution of audio frequency content 2012 ·PubMed ·(unknown), Patrick Gaydecki, Kimberley Holt, John A. Smith	30
20	Objective cough frequency in Idiopathic Pulmonary Fibrosis 2010 ·PubMed ·(unknown), Kimberley Holt, Andrew Hamilton, John A. Smith, J E Earis	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact